The term “juvenile rheumatoid arthritis (JRA)” has largely been replaced by “juvenile idiopathic arthritis (JIA).” This shift reflects a more accurate understanding that childhood-onset inflammatory arthritis is not a single disease but a group of subtypes. JIA classification includes categories such as oligoarticular, polyarticular, systemic, and enthesitis-related arthritis. While terminology changed, the clinical reality remains: early diagnosis and treat-to-target care can control inflammation and protect long-term function. Using the modern label also aligns care with current monitoring protocols—such as uveitis screening, growth tracking, and structured treatment targets—supporting guideline-consistent management.